• Ajmerun Nesha
• Nadim Siddique
• Shweeta Tiwari
• Dr. Amresh Gupta

Rheumatoid arthritis (RA) is a very heterogeneous disease, the outcome of which is difficult to predict. The vast majority of the patients will have disease progression with bone erosions and cartilage breakdown resulting in joint destruction, functional impairment, and increased mortality. The management of RA to prevent and control disease progression has changed considerably in the past few years.. This review examines data on the risks for serious infections and other key infections of interest for the major classes of agents in use for RA: glucocorticoids, conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs), & phytochemicals which originate from herbs or plants, have been used in the clinical treatment of rheumatoid arthritis (RA) for many years.

Rheumatoid arthritis, glucocorticoids, phytochemicals, immunosuppressive

"Combination of DMARD & Glucocorticoids along with phytocompounds uses in the treament of Rheumatoid Arthritis", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 9, page no.b694-b706, September-2022, Available :http://www.jetir.org/papers/JETIR2209186.pdf

"Combination of DMARD & Glucocorticoids along with phytocompounds uses in the treament of Rheumatoid Arthritis", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 9, page no. ppb694-b706, September-2022, Available at : http://www.jetir.org/papers/JETIR2209186.pdf